Summit Securities Group’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-203	Closed	-$22.5K	–	1151
2025 Q1	$22.5K	Buy	+203	New	+$22.5K	﹤0.01%	328
2014 Q1	–	Sell	-100	Closed	-$1K	–	433
2013 Q4	$1K	Buy	+100	New	+$1K	﹤0.01%	399